Clinical Presentation Analysis
The client's presentation—marked hyperglycemia (
480 mg/dL), ketonuria, and a low arterial pH of
7.25—is a classic triad for
diabetic ketoacidosis (DKA). DKA is a life-threatening metabolic emergency resulting from an absolute or relative insulin deficiency. This deficiency prevents glucose from entering cells, leading to cellular starvation. In response, the body shifts to lipolysis for energy, producing free fatty acids that the liver converts into ketone bodies (beta-hydroxybutyrate, acetoacetate). The accumulation of these strong acids overwhelms the body’s bicarbonate buffer system, causing a high anion gap metabolic acidosis
[1].
Prioritization and Rationale for IV Insulin
In the hierarchy of DKA management, the immediate priority is to halt the production of ketone bodies and reverse the acidosis. The cornerstone of this process is the administration of intravenous regular insulin. Insulin suppresses lipolysis and hepatic ketogenesis while promoting peripheral glucose uptake
[1]. A foundational principle in DKA treatment is that the insulin deficit must be corrected to resolve both the hyperglycemia and the acidosis; aggressive fluid replacement alone is insufficient
[1]. By selecting the prescribed IV regular insulin as the first action, the nurse directly targets the underlying pathophysiology. The standard of care involves a continuous IV insulin infusion, typically at a rate of
0.1 units/kg/h, which effectively and predictably lowers serum glucose and clears ketones
[3]. While recent research explores early co-administration of subcutaneous basal insulin (e.g., glargine) to shorten the duration of IV infusion, the initial and most critical step remains the initiation of IV insulin to stabilize the patient
[1].
Analysis of Incorrect Options
-
Option 2: Encourage oral fluid intake. Oral hydration is contraindicated in a patient with an altered level of consciousness or severe acidosis due to the risk of aspiration. More critically, fluid resuscitation in DKA must be precisely controlled using isotonic IV fluids to expand intravascular volume and correct dehydration, which cannot be achieved through the oral route
[1].
-
Option 3: Administer sodium bicarbonate. The use of bicarbonate in DKA is controversial and reserved only for extreme, life-threatening acidosis (typically a pH less than
6.9). Routine administration is not recommended because it can cause paradoxical cerebrospinal fluid acidosis, hypokalemia, and a delay in the clearance of ketone bodies. The primary treatment for DKA-related acidosis is insulin, which stops the production of ketoacids
[1].
-
Option 4: Monitor blood glucose every 4 hours. While glucose monitoring is an essential component of DKA management, a frequency of every 4 hours is dangerously infrequent during the acute phase. Standard protocols require hourly blood glucose monitoring to titrate the insulin infusion and prevent hypoglycemia. This intervention is important but does not take precedence over initiating the treatment that will resolve the crisis
[1].
References (research sources)
- [1]
Retrospective Evaluation of Early Glargine Administration in Adults With Diabetic Ketoacidosis.Research articleLesniak C, Gonzalez Espinosa P, Philip R, Farhat F, Ashan E, Murshad M, Gupta A, Hossain MA, Cheng J, Ong R, Chalasani K, Hu K, Akula M, Holland S. (2025) · DOI: 10.7759/cureus.90566
- [3]
Efficacy and safety of reduced-dose insulin infusion in pediatric diabetic ketoacidosis: a randomized clinical trial.RCT/clinical trialAtwa H, Ali M, Ibrahim A. (2026) · DOI: 10.1297/cpe.2025-0072